291 related articles for article (PubMed ID: 25875052)
1. Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma.
Ohtsuka M; Miura T; Mori T; Ishikawa M; Yamamoto T
JAMA Dermatol; 2015 Jul; 151(7):797-9. PubMed ID: 25875052
[No Abstract] [Full Text] [Related]
2. Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma.
Kato Y; Otsuka A; Miyachi Y; Kabashima K
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e89-e91. PubMed ID: 26388113
[No Abstract] [Full Text] [Related]
3. Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma.
Totonchy MB; Ezaldein HH; Ko CJ; Choi JN
JAMA Dermatol; 2016 May; 152(5):590-2. PubMed ID: 26675815
[No Abstract] [Full Text] [Related]
4. Vemurafenib sensitivity skin reaction after ipilimumab.
Harding JJ; Pulitzer M; Chapman PB
N Engl J Med; 2012 Mar; 366(9):866-8. PubMed ID: 22375995
[No Abstract] [Full Text] [Related]
5. Erythema multiforme major in a patient with metastatic melanoma treated with nivolumab.
Sundaresan S; Nguyen KT; Nelson KC; Ivan D; Patel AB
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469720
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma.
Matsumura N; Ohtsuka M; Kikuchi N; Yamamoto T
Acta Derm Venereol; 2016 Feb; 96(2):259-60. PubMed ID: 26270860
[No Abstract] [Full Text] [Related]
7. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
8. Intertriginous and follicular eruption to anticytotoxic T-lymphocyte antigen 4 monoclonal antibody.
Lim JL; Dahiya M; Burgin S
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S60-1. PubMed ID: 18625394
[No Abstract] [Full Text] [Related]
9. Case of de novo psoriasis possibly triggered by nivolumab.
Murata S; Kaneko S; Harada Y; Aoi N; Morita E
J Dermatol; 2017 Jan; 44(1):99-100. PubMed ID: 27177467
[No Abstract] [Full Text] [Related]
10. Cetuximab-induced acneiform eruption and the response to isotretinoin.
Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
[No Abstract] [Full Text] [Related]
11. Postherpetic Granulomatous Dermatitis in a Man Treated With Nivolumab.
Martín-Carrasco P; Pérez-Ruiz C; de Zulueta-Dorado T; Conejo-Mir J
Actas Dermosifiliogr; 2017 Oct; 108(8):783-784. PubMed ID: 28532783
[No Abstract] [Full Text] [Related]
12. Rosaceiform eruption induced by cetuximab.
Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
[No Abstract] [Full Text] [Related]
13. Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma.
Fusumae T; Kamiya K; Chiang B; Okada H; Nakano N; Maekawa T; Komine M; Murata S; Ohtsuki M
J Dermatol; 2018 Jan; 45(1):87-90. PubMed ID: 28944501
[TBL] [Abstract][Full Text] [Related]
14. First report of ipilimumab-induced Grover disease.
Munoz J; Guillot B; Girard C; Dereure O; Du-Thanh A
Br J Dermatol; 2014 Nov; 171(5):1236-7. PubMed ID: 24749658
[No Abstract] [Full Text] [Related]
15. Interleukin-2-associated bullous drug dermatosis.
Hofmann M; Audring H; Sterry W; Trefzer U
Dermatology; 2005; 210(1):74-5. PubMed ID: 15604553
[No Abstract] [Full Text] [Related]
16. Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.
Bousquet E; Zarbo A; Tournier E; Chevreau C; Mazieres J; Lacouture ME; Sibaud V
Acta Derm Venereol; 2017 Apr; 97(4):539-540. PubMed ID: 27826614
[No Abstract] [Full Text] [Related]
17. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
de Groot M; de Rie MA; Bos JD
Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
[No Abstract] [Full Text] [Related]
18. Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.
Napolitano M; Scalvenzi M; Fabbrocini G; Cinelli E; Patruno C
Dermatol Ther; 2019 Nov; 32(6):e13142. PubMed ID: 31664761
[No Abstract] [Full Text] [Related]
19. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
Ferguson NN; Asarch A; VanBeek M; Swick BL
Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.
Mochel MC; Ming ME; Imadojemu S; Gangadhar TC; Schuchter LM; Elenitsas R; Payne AS; Chu EY
J Cutan Pathol; 2016 Sep; 43(9):787-91. PubMed ID: 27161449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
